HEADER VIRAL PROTEIN/IMMUNE SYSTEM 27-SEP-20 7K8M TITLE STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH TITLE 2 THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102 COMPND MOL_ID: 1; COMPND 2 MOLECULE: C102 FAB HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: C102 FAB LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE GLYCOPROTEIN; COMPND 11 CHAIN: E; COMPND 12 FRAGMENT: RECEPTOR BINDING DOMAIN (UNP RESIDUES 331-517); COMPND 13 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 19 2; SOURCE 20 ORGANISM_COMMON: 2019-NCOV; SOURCE 21 ORGANISM_TAXID: 2697049; SOURCE 22 GENE: S, 2; SOURCE 23 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 24 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 26 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS HUMAN NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR BINDING DOMAIN, KEYWDS 2 COVID-19, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.A.JETTE,C.O.BARNES,P.J.BJORKMAN REVDAT 5 18-OCT-23 7K8M 1 REMARK REVDAT 4 20-JAN-21 7K8M 1 COMPND SOURCE DBREF REVDAT 3 13-JAN-21 7K8M 1 JRNL REVDAT 2 28-OCT-20 7K8M 1 TITLE REVDAT 1 21-OCT-20 7K8M 0 JRNL AUTH C.O.BARNES,C.A.JETTE,M.E.ABERNATHY,K.A.DAM,S.R.ESSWEIN, JRNL AUTH 2 H.B.GRISTICK,A.G.MALYUTIN,N.G.SHARAF,K.E.HUEY-TUBMAN, JRNL AUTH 3 Y.E.LEE,D.F.ROBBIANI,M.C.NUSSENZWEIG,A.P.WEST JR., JRNL AUTH 4 P.J.BJORKMAN JRNL TITL SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM JRNL TITL 2 THERAPEUTIC STRATEGIES. JRNL REF NATURE V. 588 682 2020 JRNL REFN ESSN 1476-4687 JRNL PMID 33045718 JRNL DOI 10.1038/S41586-020-2852-1 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.12 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 14713 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1470 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 52.1200 - 7.1200 0.99 1306 144 0.1742 0.2214 REMARK 3 2 7.1100 - 5.6500 1.00 1234 138 0.1785 0.2208 REMARK 3 3 5.6500 - 4.9300 1.00 1213 134 0.1358 0.1983 REMARK 3 4 4.9300 - 4.4800 1.00 1201 134 0.1276 0.1820 REMARK 3 5 4.4800 - 4.1600 1.00 1185 131 0.1421 0.2342 REMARK 3 6 4.1600 - 3.9200 1.00 1206 134 0.1683 0.2174 REMARK 3 7 3.9200 - 3.7200 1.00 1187 132 0.1876 0.2638 REMARK 3 8 3.7200 - 3.5600 1.00 1196 132 0.2114 0.3027 REMARK 3 9 3.5600 - 3.4200 1.00 1167 130 0.2354 0.2629 REMARK 3 10 3.4200 - 3.3000 1.00 1197 133 0.2400 0.2978 REMARK 3 11 3.3000 - 3.2000 0.99 1151 128 0.2802 0.3439 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.396 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.082 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 77.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4863 REMARK 3 ANGLE : 0.693 6616 REMARK 3 CHIRALITY : 0.044 727 REMARK 3 PLANARITY : 0.004 855 REMARK 3 DIHEDRAL : 16.360 1740 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7K8M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1000251581. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAY-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14722 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 52.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 7BZ5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE TRIBASIC, 20% W/V REMARK 280 PEG3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.29950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.54450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.62500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.54450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.29950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.62500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 129 REMARK 465 SER A 130 REMARK 465 THR A 131 REMARK 465 SER A 132 REMARK 465 GLY A 133 REMARK 465 GLY A 134 REMARK 465 CYS A 216 REMARK 465 ASP A 217 REMARK 465 LYS A 218 REMARK 465 THR A 219 REMARK 465 HIS A 220 REMARK 465 HIS A 221 REMARK 465 HIS A 222 REMARK 465 HIS A 223 REMARK 465 HIS A 224 REMARK 465 HIS A 225 REMARK 465 ASN E 331 REMARK 465 ILE E 332 REMARK 465 THR E 333 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 1 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 99 OH TYR E 453 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 48 -68.77 -109.39 REMARK 500 ALA A 88 172.57 178.41 REMARK 500 TYR A 99 -96.01 -118.16 REMARK 500 SER A 113 36.39 -94.35 REMARK 500 LEU A 178 118.31 -169.06 REMARK 500 LEU A 189 -9.70 -57.66 REMARK 500 PRO B 44 154.30 -43.87 REMARK 500 SER B 52 -43.42 -150.88 REMARK 500 ALA B 55 -175.02 -64.52 REMARK 500 TYR B 91 26.57 -141.54 REMARK 500 ASN B 138 88.88 50.15 REMARK 500 TYR B 140 140.46 179.35 REMARK 500 LYS B 169 -77.65 -111.44 REMARK 500 LYS B 190 -71.96 -109.73 REMARK 500 PRO E 337 48.75 -81.34 REMARK 500 ALA E 352 52.24 -107.20 REMARK 500 ASN E 360 60.59 64.66 REMARK 500 ASN E 370 76.40 -114.12 REMARK 500 SER E 371 -39.44 -134.47 REMARK 500 ALA E 372 -23.72 74.70 REMARK 500 ASN E 422 -59.58 -130.56 REMARK 500 ASP E 428 49.49 -92.14 REMARK 500 REMARK 500 REMARK: NULL DBREF 7K8M A 1 225 PDB 7K8M 7K8M 1 225 DBREF 7K8M B 1 214 PDB 7K8M 7K8M 1 214 DBREF 7K8M E 331 517 UNP P0DTC2 SPIKE_SARS2 331 517 SEQRES 1 A 229 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU ILE GLN SEQRES 2 A 229 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 A 229 PHE ILE VAL SER SER ASN TYR MET SER TRP VAL ARG GLN SEQRES 4 A 229 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER VAL ILE TYR SEQRES 5 A 229 SER GLY GLY SER THR PHE TYR ALA ASP SER VAL LYS GLY SEQRES 6 A 229 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR LEU SEQRES 7 A 229 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 A 229 VAL TYR TYR CYS ALA ARG ASP TYR GLY ASP TYR TYR PHE SEQRES 9 A 229 ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SER SEQRES 10 A 229 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 11 A 229 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 12 A 229 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 13 A 229 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 14 A 229 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 15 A 229 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 16 A 229 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 17 A 229 THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SER CYS ASP SEQRES 18 A 229 LYS THR HIS HIS HIS HIS HIS HIS SEQRES 1 B 215 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 B 215 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 B 215 GLN SER VAL SER SER SER TYR LEU ALA TRP TYR GLN GLN SEQRES 4 B 215 LYS PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SEQRES 5 B 215 SER SER ARG ALA THR GLY ILE PRO ASP ARG PHE SER GLY SEQRES 6 B 215 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 B 215 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 B 215 TYR GLY SER SER PRO ARG THR PHE GLY GLN GLY THR LYS SEQRES 9 B 215 VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 B 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 B 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 B 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 B 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 B 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 B 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 B 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 B 215 SER PHE ASN ARG GLY GLU CYS SEQRES 1 E 187 ASN ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN SEQRES 2 E 187 ALA THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS SEQRES 3 E 187 ARG ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR SEQRES 4 E 187 ASN SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SEQRES 5 E 187 SER PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL SEQRES 6 E 187 TYR ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG SEQRES 7 E 187 GLN ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR SEQRES 8 E 187 ASN TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE SEQRES 9 E 187 ALA TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY SEQRES 10 E 187 ASN TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN SEQRES 11 E 187 LEU LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR SEQRES 12 E 187 GLN ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE SEQRES 13 E 187 ASN CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO SEQRES 14 E 187 THR ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL SEQRES 15 E 187 LEU SER PHE GLU LEU HET NAG E 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG C8 H15 N O6 HELIX 1 AA1 ILE A 28 ASN A 32 5 5 HELIX 2 AA2 ASP A 61 LYS A 64 5 4 HELIX 3 AA3 ARG A 83 THR A 87 5 5 HELIX 4 AA4 PRO A 185 LEU A 189 5 5 HELIX 5 AA5 LYS A 201 ASN A 204 5 4 HELIX 6 AA6 SER B 29 SER B 31 5 3 HELIX 7 AA7 SER B 121 SER B 127 1 7 HELIX 8 AA8 LYS B 183 GLU B 187 1 5 HELIX 9 AA9 PHE E 338 ASN E 343 1 6 HELIX 10 AB1 SER E 349 TRP E 353 5 5 HELIX 11 AB2 TYR E 365 ASN E 370 1 6 HELIX 12 AB3 ASP E 405 ILE E 410 5 6 HELIX 13 AB4 GLY E 416 ASN E 422 1 7 HELIX 14 AB5 GLY E 502 TYR E 505 5 4 SHEET 1 AA1 4 GLN A 3 SER A 7 0 SHEET 2 AA1 4 LEU A 18 SER A 25 -1 O ALA A 23 N VAL A 5 SHEET 3 AA1 4 THR A 77 MET A 82 -1 O MET A 82 N LEU A 18 SHEET 4 AA1 4 PHE A 67 ASP A 72 -1 N THR A 68 O GLN A 81 SHEET 1 AA2 6 LEU A 11 ILE A 12 0 SHEET 2 AA2 6 THR A 107 VAL A 111 1 O THR A 110 N ILE A 12 SHEET 3 AA2 6 ALA A 88 ASP A 95 -1 N TYR A 90 O THR A 107 SHEET 4 AA2 6 TYR A 33 GLN A 39 -1 N VAL A 37 O TYR A 91 SHEET 5 AA2 6 LEU A 45 ILE A 51 -1 O VAL A 48 N TRP A 36 SHEET 6 AA2 6 THR A 57 TYR A 59 -1 O PHE A 58 N VAL A 50 SHEET 1 AA3 4 LEU A 11 ILE A 12 0 SHEET 2 AA3 4 THR A 107 VAL A 111 1 O THR A 110 N ILE A 12 SHEET 3 AA3 4 ALA A 88 ASP A 95 -1 N TYR A 90 O THR A 107 SHEET 4 AA3 4 PHE A 100A TRP A 103 -1 O TYR A 102 N ARG A 94 SHEET 1 AA4 4 SER A 120 LEU A 124 0 SHEET 2 AA4 4 ALA A 136 TYR A 145 -1 O GLY A 139 N LEU A 124 SHEET 3 AA4 4 TYR A 176 VAL A 184 -1 O TYR A 176 N TYR A 145 SHEET 4 AA4 4 VAL A 163 THR A 165 -1 N HIS A 164 O VAL A 181 SHEET 1 AA5 4 SER A 120 LEU A 124 0 SHEET 2 AA5 4 ALA A 136 TYR A 145 -1 O GLY A 139 N LEU A 124 SHEET 3 AA5 4 TYR A 176 VAL A 184 -1 O TYR A 176 N TYR A 145 SHEET 4 AA5 4 VAL A 169 LEU A 170 -1 N VAL A 169 O SER A 177 SHEET 1 AA6 3 THR A 151 TRP A 154 0 SHEET 2 AA6 3 TYR A 194 HIS A 200 -1 O ASN A 197 N SER A 153 SHEET 3 AA6 3 THR A 205 VAL A 211 -1 O VAL A 207 N VAL A 198 SHEET 1 AA7 3 LEU B 4 SER B 7 0 SHEET 2 AA7 3 ALA B 19 VAL B 28 -1 O ARG B 24 N THR B 5 SHEET 3 AA7 3 PHE B 62 ILE B 75 -1 O ILE B 75 N ALA B 19 SHEET 1 AA8 6 THR B 10 LEU B 13 0 SHEET 2 AA8 6 THR B 102 ILE B 106 1 O LYS B 103 N LEU B 11 SHEET 3 AA8 6 VAL B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA8 6 LEU B 33 GLN B 38 -1 N ALA B 34 O GLN B 89 SHEET 5 AA8 6 ARG B 45 TYR B 49 -1 O LEU B 47 N TRP B 35 SHEET 6 AA8 6 SER B 53 ARG B 54 -1 O SER B 53 N TYR B 49 SHEET 1 AA9 4 THR B 10 LEU B 13 0 SHEET 2 AA9 4 THR B 102 ILE B 106 1 O LYS B 103 N LEU B 11 SHEET 3 AA9 4 VAL B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA9 4 THR B 97 PHE B 98 -1 O THR B 97 N GLN B 90 SHEET 1 AB1 4 SER B 114 PHE B 118 0 SHEET 2 AB1 4 THR B 129 PHE B 139 -1 O ASN B 137 N SER B 114 SHEET 3 AB1 4 TYR B 173 SER B 182 -1 O LEU B 181 N ALA B 130 SHEET 4 AB1 4 SER B 159 GLN B 160 -1 N GLN B 160 O THR B 178 SHEET 1 AB2 4 ALA B 153 GLN B 155 0 SHEET 2 AB2 4 ALA B 144 VAL B 150 -1 N VAL B 150 O ALA B 153 SHEET 3 AB2 4 VAL B 191 HIS B 198 -1 O GLU B 195 N GLN B 147 SHEET 4 AB2 4 VAL B 205 ASN B 210 -1 O VAL B 205 N VAL B 196 SHEET 1 AB3 5 ASN E 354 ILE E 358 0 SHEET 2 AB3 5 ASN E 394 ARG E 403 -1 O ALA E 397 N LYS E 356 SHEET 3 AB3 5 PRO E 507 GLU E 516 -1 O TYR E 508 N ILE E 402 SHEET 4 AB3 5 GLY E 431 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 5 AB3 5 THR E 376 TYR E 380 -1 N TYR E 380 O GLY E 431 SHEET 1 AB4 2 LEU E 452 ARG E 454 0 SHEET 2 AB4 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AB5 2 TYR E 473 GLN E 474 0 SHEET 2 AB5 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SSBOND 1 CYS A 22 CYS A 92 1555 1555 2.04 SSBOND 2 CYS A 140 CYS A 196 1555 1555 2.03 SSBOND 3 CYS B 23 CYS B 88 1555 1555 2.05 SSBOND 4 CYS B 134 CYS B 194 1555 1555 2.04 SSBOND 5 CYS E 336 CYS E 361 1555 1555 2.03 SSBOND 6 CYS E 379 CYS E 432 1555 1555 2.04 SSBOND 7 CYS E 480 CYS E 488 1555 1555 2.03 LINK ND2 ASN E 343 C1 NAG E 601 1555 1555 1.45 CISPEP 1 PHE A 146 PRO A 147 0 -3.17 CISPEP 2 GLU A 148 PRO A 149 0 -5.58 CISPEP 3 SER B 7 PRO B 8 0 -2.83 CISPEP 4 SER B 94 PRO B 95 0 -1.86 CISPEP 5 TYR B 140 PRO B 141 0 -1.13 CRYST1 54.599 89.250 175.089 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018315 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011204 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005711 0.00000